PYC pyc therapeutics limited

Ann: PYC Therapeutics Investor Call - 18 August 2022, page-20

  1. 125 Posts.
    lightbulb Created with Sketch. 100
    Back in the game actively accumulating at broker induced prices, advantageous for broker’s clients. US is awash with merger/ license deal activity in an oversold sector. Rohan had mentioned to explore the OZ market before engaging in renewed partnership discussions in the US with new data. Current prices are either perfect entry level or welcomed averting down opportunity. Director’s purchase at 6.1 average should mark the bottom, triple tested.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.25
Change
-0.050(3.85%)
Mkt cap ! $723.2M
Open High Low Value Volume
$1.26 $1.26 $1.24 $75.83K 60.82K

Buyers (Bids)

No. Vol. Price($)
3 8331 $1.25
 

Sellers (Offers)

Price($) Vol. No.
$1.27 12215 5
View Market Depth
Last trade - 14.17pm 07/08/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.